Open-label pilot study of modafinil for methamphetamine dependence

Journal of Clinical Psychopharmacology

Volumn 29, Issue 5, 2009, Pages 488-491

  McGaugh, Janette ^a   Mancino, Michael J ^b   Feldman, Zachary ^b   Chopra, Mohit P ^c   Gentry, W Brooks ^b   Cargile, Christopher ^b   Oliveto, Alison ^b  

^a Medical Department   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Methamphetamine dependence; Modafinil; Open label clinical trial; Safety; Tolerability

Indexed keywords

METHAMPHETAMINE; MODAFINIL;

ADULT; ANXIETY; ARTICLE; BACKACHE; BLISTER PACK; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG DEPENDENCE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HEADACHE; HEART RATE; HUMAN; INSOMNIA; MALE; NAUSEA; NERVOUSNESS; PRIORITY JOURNAL; RHINITIS; SELF REPORT; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; AMPHETAMINE-RELATED DISORDERS; BENZHYDRYL COMPOUNDS; FEMALE; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; PILOT PROJECTS;

EID: 70349670712     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181b591e0     Document Type: Article

References (29)

1. Baberg HT, Nelesen RA, Dimsdale JE. Amphetamine use: return of an old scourge in a consultation psychiatry setting. Am J Psychiatry. 1996;153:789-793.
2. Shaw KP. Human methamphetamine-related fatalities in Taiwan during 1991-1996. J Forensic Sci. 1999;44:27-31.
3. National Association of Countries. The Meth Epidemic in America: Two Surveys of U.S. Counties: The Criminal Effect of Meth on Communities, the Impact of Meth on Children. Washington, DC: National Association of Countries; 2005.
4. Ellinwood EH Jr, Kilbey MM. Fundamental mechanisms underlying altered behavior following chronic administration of psychomotor stimulants. Biol Psychiatry. 1980;15:749-757.
5. Abi-Dargham A, Kegeles LS, Martinez D, et al. Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naive healthy volunteers: results from a large cohort. Eur Neuropsychopharmacol. 2003;13:459-468.
6. Marek GJ, Vosmer G, Seiden LS. Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons. Brain Res. 1990;513:274-279.
7. Kitayama S, Dohi T. Cellular and molecular aspects of monoamine neurotransmitter transporters. Jpn J Pharmacol. 1996;72:195-208.
8. Fleckenstein AE, Metzger RR, Wilkins DG, et al. Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther. 1997;282:834-838.
9. Zhang Y, Loonam TM, Noailles PA, et al. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann N Y Acad Sci. 2001; 937:93-120.
10. Physicians' Desk Reference. 59th ed. Thomson PDR: Montvale, NJ; 2005.
11. Hou YP, Lin JS. Effects of modafinil and amphetamine on sleep-wake cycle after sleep deprivation in cats. Acta Pharmacol Sin. 1999;20:813-818.
12. Engber TM, Dennis SA, Jones BE, et al. Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine. Neuroscience. 1998;87:905-911.
13. De Sereville JE, Boer C, Rambert FA, et al. Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: in vivo voltammetry studies. Neuropharmacology. 1994;33:755-761.
14. Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Nat Acad Sci U S A. 1996;93:14128-14133.
15. Wisor JP, Nishino S, Sora I, et al. Dopaminergic role in stimulant-induced wakefulness. J Neuroscience. 2001;21:1787-1794.
16. Dackis DA, Lynch LG, Yu E, et al. Modafinil and cocaine: A double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend. 2003;70:29-37.
17. Dackis CA, Kampman KM, Lynch KG, et al. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology. 2005;30:205-211.
18. McElhiney MC, Rabkin JG, Rabkin R, et al. Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: A pilot study. Am J Drug Alcohol Abuse. 2009;35:34-37.
19. Shearer J, Darke S, Rodgers C, et al. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction. 2009;104:224-233.
20. McGregor C, Srisurapanont M, Mitchell A, et al. Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual. J Subst Abuse Treat. 2008;35:334-342.
21. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV, Patient Edition. Washington, DC: American Psychiatric Press; 1995.
22. McLellan AT, Luborsky L, Woody GE, et al. An improved diagnostic instrument for substance abuse subjects: the Addiction Severity Index. J Nerv Mental Dis. 1980;168:26-33.
23. Hamilton MA. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
24. Kosten TR, Oliveto A, Feingold A, et al. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend. 2003;70:315-325.
25. Oliveto A, Poling J, Sevarino K, et al. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients. Drug Alcohol Depend. 2005;79:157-166.
26. Bryk AS, Raudenbush SW. Application of hierarchical linear models to assessing change. Psychological Bull. 1987;101:147-158.
27. Gibbons RD, Hedeker D, Elkin I, et al. Some conceptual and statistical issues in analyses of longitudinal psychiatric data. Arch Gen Psychiatry. 1993;50:739-750.
28. Hart CL, Haney M, Vosburg SK, et al. Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology. 2008;33:761-768.
29. Camacho A, Stein MB. Modafinil for social phobia and amphetamine dependence. Am J Psychiatry. 2002;159:1947-1948.